Log in or Sign up for Free to view tailored content for your specialty!
Hormone Therapy News
Bone density decreases when stopping, never using menopausal hormone therapy
Postmenopausal women who stopped or never used hormone therapy over a 5-year period experienced a loss in bone density, whereas bone density was maintained for those who continued treatment, researchers reported in Menopause.
Testosterone treatment boosts hemoglobin levels for older men with anemia
Testosterone therapy increases hemoglobin levels for older men with anemia and is linked to a lower likelihood for developing anemia for men without the condition, according to study data.
Log in or Sign up for Free to view tailored content for your specialty!
Menopausal hormone therapy may increase risk for late-onset rheumatoid arthritis
Oral contraceptives may protect against rheumatoid arthritis, while menopausal hormone therapy could increase risk for late-onset RA, according to data published in Rheumatology.
Testosterone replacement does not improve steatotic liver disease for older men
Twelve months of testosterone replacement therapy did not improve metabolic dysfunction-associated steatotic liver disease in a group of older men with hypogonadism, according to a secondary analysis of the T Trials.
VIDEO: Monitor weight, cardiometabolic factors for adults receiving gender-confirming HT
DALLAS — In this Healio video exclusive, Michael S. Irwig, MD, discusses how gender-confirming hormone therapy may affect obesity and cardiometabolic health.
Use of sex-specific troponin levels does not impact MI outcomes for transgender patients
Implementing sex-specific troponin thresholds for diagnosing acute MI did not significantly affect outcomes for transgender patients, researchers reported.
Generational decline in testosterone levels observed
During the past two decades, testosterone levels in American men have rapidly declined.
Should men with symptoms of low testosterone — but without hypogonadism — be prescribed testosterone therapy?
PoinT
Higher endometrial cancer, hyperplasia rates with conjugated estrogens/bazedoxifene
In the first years of use, women prescribed conjugated estrogens/bazedoxifene vs. estrogen/progestin for menopausal symptoms may have higher rates of endometrial cancer and endometrial hyperplasia but lower breast cancer rates.
Not ‘panacea nor poison’: No long-term cognitive effects of menopausal hormone therapy
PHILADELPHIA — At 10 years of follow-up, women who had been assigned menopausal hormone therapy in the KEEPS study had cognitive function scores similar to those of women assigned placebo, according to a speaker.
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read